Drug Price Trends for OXYCODONE-ASPIRIN

OXYCODONE-ASPIRIN Market Analysis and Financial Projection

Market Analysis and Price Projections for Oxycodone-Acetaminophen (and related formulations like Oxycodone-Aspirin)

Introduction to Oxycodone-Acetaminophen

Oxycodone-acetaminophen, commonly known by brand names such as Percocet, is a widely used opioid analgesic combination for managing moderate to severe pain. While the specific formulation of oxycodone-aspirin is less common, the market dynamics and price projections for oxycodone-acetaminophen can provide valuable insights into the broader opioid market.

Market Size and Growth

The global opioids market, which includes oxycodone-acetaminophen, was valued at $4.4 billion in 2020 and is projected to reach $6.1 billion by 2030, growing at a CAGR of 3.2% from 2021 to 2030[4].

Key Drivers of Market Growth

1. Increasing Demand for Pain Management

   • The rise in chronic pain conditions, such as backaches, migraines, and cancer-related pain, drives the demand for opioids like oxycodone-acetaminophen[4].

2. Geriatric Population

   • The growing geriatric population, which is more prone to orthopedic and other chronic pains, contributes significantly to the market growth[4].

3. Disposable Income in Developing Economies

   • An increase in disposable income in countries like India and China also boosts the demand for opioid medications[4].

Price Dynamics

Retail Prices Without Insurance

• The average retail price for 30 tablets of oxycodone-acetaminophen (5-325 mg) is approximately $45, which translates to about $1.50 per tablet[2].
• For oxycodone-aspirin or similar formulations, prices can vary but generally follow the trend of other opioid combinations.

Impact of Insurance and Discount Programs

• Oxycodone-acetaminophen is often covered by health insurance, Medicare Part D, and Medicaid, which can significantly reduce the out-of-pocket (OOP) costs for patients[2].
• Prescription discount cards, such as those offered by SingleCare, can reduce the cost of oxycodone-acetaminophen to as low as $13 for 30 tablets[2].

Price Elasticity

• The demand for prescription opioids, including oxycodone-acetaminophen, is relatively price-sensitive. Studies have shown a price elasticity of -0.9, indicating that consumers are more responsive to price changes for opioids compared to other prescription drugs[3].

Market Segmentation

By Type

• The opioids market is segmented into various types, including codeine, fentanyl, oxycodone, methadone, morphine, and hydrocodone. Oxycodone was the major revenue contributor in 2020 and is expected to continue this trend[4].

By Application

• The pain management segment dominates the opioids market, driven by the need to manage chronic and severe pain in various patient groups[4].

Regional Analysis

• North America holds the largest share of the opioids market, primarily due to the high prevalence of chronic pain and the presence of major pharmaceutical companies. The Asia-Pacific region is expected to witness the fastest growth due to increasing focus by companies like Purdue Pharma[4].

Impact of Regulatory Changes

• Regulatory changes, such as the introduction of abuse-deterrent formulations (e.g., abuse-deterrent OxyContin in 2010) and the withdrawal of certain opioids (e.g., propoxyphene in 2010), have significantly impacted opioid dispensing and overdose rates. These changes led to a 20% decrease in prescription opioid overdose rates two years after implementation[1].

Competition Analysis

• The opioids market is competitive, with key players including Purdue Pharma LP, AstraZeneca Plc., C.H. Boehringer Sohn Ag and Ko. Kg, and Johnson & Johnson, Inc. These companies continually innovate and adapt to regulatory changes to maintain their market share[4].

Future Trends

• Increased Focus on Abuse-Deterrent Formulations: There will be a continued emphasis on developing and prescribing abuse-deterrent opioid formulations to mitigate the risk of misuse and overdose.

• Rise in Alternative Pain Management Options: The market may see a shift towards non-opioid pain relief options due to growing concerns about opioid addiction and overdose.

• Expansion in Emerging Markets: Companies are expected to focus more on emerging economies, where there is a growing demand for pain management solutions.

Key Takeaways

• The global opioids market, including oxycodone-acetaminophen, is expected to grow due to increasing demand for pain management.
• Prices for oxycodone-acetaminophen can be significantly reduced with insurance and discount programs.
• Regulatory changes and the development of abuse-deterrent formulations are crucial in shaping the market.
• The market is highly competitive, with major pharmaceutical companies driving innovation.

FAQs

1. What is the average retail price of oxycodone-acetaminophen without insurance?

   • The average retail price for 30 tablets of oxycodone-acetaminophen (5-325 mg) is approximately $45[2].

2. How do insurance and discount programs affect the cost of oxycodone-acetaminophen?

   • Insurance and discount programs can significantly reduce the cost, with some programs offering prices as low as $13 for 30 tablets[2].

3. What are the key drivers of the opioids market growth?

   • The key drivers include increasing demand for pain management, a growing geriatric population, and rising disposable income in developing economies[4].

4. How does price elasticity affect the demand for oxycodone-acetaminophen?

   • The demand for oxycodone-acetaminophen is relatively price-sensitive, with a price elasticity of -0.9, indicating that consumers are responsive to price changes[3].

5. What are the future trends in the opioids market?

   • Future trends include a focus on abuse-deterrent formulations, a rise in alternative pain management options, and expansion into emerging markets[4].

Sources

1. Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent OxyContin and Withdrawal of Propoxyphene - JAMA Internal Medicine[1]
2. Oxycodone acetaminophen without insurance - SingleCare[2]
3. Health Insurance, Price Changes, and the Demand for Pain Relief Drugs - Kelley School of Business, Indiana University[3]
4. Opioids Market Size, Share, Demand & Growth Report, 2030 - Allied Market Research[4]